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Abstract 
Purpose: This study aimed to compare the interobserver variabilities in magnetic resonance 
imaging (MRI)/computed tomography (CT) fusion image-based post-implant dosimetry of 
permanent prostate brachytherapy (PPB) between 1.5-T and 3.0-T MRI. Materials: The study 
included 60 patients. Of these patients, 30 underwent 1.5-T MRI and CT 30 days after seed 
implantation (1.5-T group) and 30 underwent 3.0-T MRI and CT 30 days after seed 
implantation (3.0-T group). All patients received PPB alone. Two radiation oncologists 
performed MRI/CT fusion image-based post-implant dosimetry, and the interobserver 
variabilities of dose–volume histogram (DVH) parameters (prostate D90, prostate V100, 
prostate V150, urethral D5, and urethral V150) were retrospectively estimated using the paired 
Student’s t test and Pearson’s correlation coefficient. Results: The Pearson’s correlation 
coefficients of all DVH parameters were higher in the 3.0-T group than in the 1.5-T group 
(1.5-T vs. 3.0-T: prostate D90, 0.65 vs. 0.93; prostate V100, 0.62 vs. 0.82; prostate V150, 0.97 
vs. 0.98; urethral D5, 0.92 vs. 0.93; and urethral V150, 0.88 vs. 0.93). In the paired Student’s t 
test, no significant differences were observed in all DVH parameters between the two radiation 
oncologists in the 3.0-T group (0.068 ≤ p ≤ 0.842); however, significant differences were 
observed in prostate D90 (p = 0.004), prostate V100 (p = 0.011), and prostate V150 (p = 
0.002) between the oncologists in the 1.5-T group. Conclusions: The interobserver variability 
of DVH parameters in the MRI/CT fusion image-based post-implant dosimetry analysis of 
brachytherapy was lower with 3.0-T MRI than with 1.5-T MRI. 
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